The ASCO Annual Meeting enters its second year in a virtual setting June 4-8, 2021, to ensure the safety and health of attendees while delivering groundbreaking science in oncology and timely information on clinical application and treatment new scientific data to the oncology community.
ASCO’s robust scientific and education meeting platform will provide attendees with live and on-demand access to top caliber scientific research presentations and slides. The online meeting experience will also offer opportunities to engage with and learn from oncology thought leaders from around the world, including interactivity and live question and answer in key sessions.
Keep an Eye Out for Pivotal Trials…
OlympiA: A phase III, multicenter, randomized, placebo-controlled trial of adjuvant olaparib after (neo)adjuvant chemotherapy in patients with germline BRCA1/2 mutations and high-risk HER2-negative early breast cancer (Abstract LBA1).
EFFORT: EFFicacy Of adavosertib in parp ResisTance: A randomized two-arm non-comparative phase II study of adavosertib with or without olaparib in women with PARP-resistant ovarian cancer. (Abstract 5505)
Optimal treatment duration of bevacizumab (BEV) combined with carboplatin and paclitaxel in patients (pts) with primary epithelial ovarian (EOC), fallopian tube (FTC) or peritoneal cancer (PPC): a multicenter open-label randomized 2-arm phase 3 ENGOT/GCIG trial (Abstract 5501).
Phase IIb VITAL Trial: Maintenance vigil immunotherapy in newly diagnosed advanced ovarian cancer: Efficacy assessment of homologous recombination proficient (HRP) patients in the (Abstract 5502).
And many more!
Registration
Registration for the Meeting is open and includes access all Education and Scientific Sessions, Poster Sessions, Online Exhibits, 2021 ASCO Annual Meeting Videos and Slides, Annual Meeting Proceedings, and ASCO Educational Book – as well as access to an online platform with interactive tools and Q&A.
Access to Content
Content will be delivered in two formats: on-demand and through a scheduled broadcast. The on-demand content will be comprised of 175 sessions—formats include Oral Abstract Sessions, Poster Sessions, Poster Discussion Sessions, and track-specific Clinical Science Symposia—and will be available on June 4 at 9:00 AM EST.
The scheduled broadcast will include 48 high-impact sessions with real-time engagement, live Q&A, and unparalleled learning; these sessions will begin on June 4 at 11:00 AM EST. Sessions will be available on-demand 2 hours after airing. Search the Digital Program and the Broadcast Schedule to plan your meeting experience.
For more information, visit: ASCO 2021 Annual Meeting
